Louis lipedema treatment, continues to monitor and evaluate the benefits of Ozempic and other emerging treatments for lipedema
To view or add a comment, sign in FDA proposes ban on Orange B, a food dye not used for decades Source: The Independent To view or add a comment, sign in New FDA Matters column: "Weedy Concerns Amidst a Flood of FDA Issues" As an advocate for a more effective, efficient, and fair FDA, I have compiled a roundup of some of the most concerning FDA issues as of September 26, 2025
Preclinical studies consistently show that GLP-1 receptor agonists (GLP-1RAs) have a protective effect on muscles, but in human experiments, their efficacy presents a high degree of dual effects and heterogeneity
The fatigue usually improves within a few weeks as your body adjusts to operating on fewer calories
Instead, this paper focuses on Glucagon-Like Peptide-1 receptor agonists (GLP-1 RAs) as commonly used anti-obesity medications (AOMs) and summarizes the current evidence on their efficacy and safety, particularly from the perspective of sarcopenia in older adults
Those who took tirzepatide weekly reduced their risk of developing type 2 diabetes by up to 94 percent compared to those who didn't take the medication